From: Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer
Variable | ORa | 95% CIa | Adjusted Pa |
---|---|---|---|
Age at diagnosis (years) | |||
<50 | Referent | ||
50 to 69 | 0.769 | 0.463 to 1.275 | 0.308 |
≥70 | 0.410 | 0.212 to 0.793 | 0.008 |
Comorbidities | |||
None | Referent | ||
One or more | 1.033 | 0.791 to 1.349 | 0.811 |
Menopausal status | |||
Premenopause | Referent | ||
Menopause | 1.205 | 0.734 to 1.979 | 0.461 |
Residential status | |||
Rural | Referent | ||
Urban | 1.381 | 1.083 to 1.761 | 0.009 |
Tumor size | |||
≤2 | Referent | ||
>2 | 0.828 | 0.603 to 1.136 | 0.242 |
Lymph node metastasis | |||
Negative | Referent | ||
Positive | 1.600 | 1.266 to 2.022 | <0.001 |
Distant metastasis | |||
Negative | Referent | ||
Positive | 1.123 | 0.282 to 4.475 | 0.869 |
Hormone receptor status | |||
ER- and PR- | Referent | ||
ER + and/or PR+ | 1.364 | 0.979 to 1.900 | 0.066 |